Thyroid artery embolization review raises substantial safety concerns
Reports described symptom relief in some thyroid conditions, but limited evidence and serious complications prevented the reviewers from supporting routine use.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review found limited reports of smaller goiters, symptom relief and normalized thyroid function in some patients after thyroid arterial embolization. It also identified serious complications, including embolization outside the intended target and death. The authors concluded that weak evidence and the absence of a standardized safe protocol prevent recommending routine use.
The abstract does not give complication rates, effect estimates, follow-up lengths or clear comparison groups. Reports across different thyroid conditions cannot establish a reliable overall balance of benefit and harm.
What the procedure aims to do
Thyroid arterial embolization reduces blood flow to the thyroid by introducing particles into arteries supplying the gland. The review examined its reported safety and effectiveness across several thyroid diseases, rather than a single clearly defined patient group.
Reported benefits varied by diagnosis
Some reports described smaller goiters or relief of symptoms, while thyroid function normalized in some people with Graves' disease. In cancer, reports concerned symptom relief and facilitating surgery. These outcomes should not be treated as interchangeable.
The original publication
Thyroid Arterial Embolization for the Management of Benign and Malignant Thyroid Disease: A Systematic Review.
Coerts HI, D'Mello B, Verburg FA et al.
Endocr Pract · 2026
- PubMed ID
- 40780312
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.